Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo

Journal of Controlled Release

Volumn 167, Issue 1, 2013, Pages 76-84

  Xu, Qingguo ^a,c   Boylan, Nicholas J ^b,c   Suk, Jung Soo ^a,c   Wang, Ying Ying ^c   Nance, Elizabeth A ^b,c   Yang, Jeh Chang ^b   McDonnell, Peter J ^a,c   Cone, Richard A ^c   Duh, Elia J ^a,c   Hanes, Justin ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Johns Hopkins University   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug delivery; Eye; Gene delivery; Nanotechnology; Particle tracking

Indexed keywords

BIODEGRADABLE NANOPARTICLE; EYE; GENE DELIVERY; NEGATIVELY CHARGED SURFACES; PARTICLE TRACKING; POLY(LACTIC-CO-GLYCOLIC ACID); POLYETHYLENE GLYCOL (PEG); POSITIVELY CHARGED SURFACES;

CHARGED PARTICLES; COPOLYMERS; DRUG DELIVERY; GENE THERAPY; GENE TRANSFER; NANOPARTICLES; NANOTECHNOLOGY; POLYSTYRENES; SURFACE CHEMISTRY;

MAMMALS;

DNA; MACROGOL; NANOPARTICLE; POLYGLACTIN; POLYSTYRENE; POLYVINYL ALCOHOL;

ARTICLE; CONCENTRATION (PARAMETERS); HYDRODYNAMICS; NONHUMAN; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; VITREOUS BODY;

ANIMALS; CATTLE; DIFFUSION; DNA; ELASTIC MODULUS; NANOPARTICLES; POLYMERS; RHEOLOGY; SURFACE PROPERTIES; VISCOSITY; VITREOUS BODY;

EID: 84874001319     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.01.018     Document Type: Article

References (52)

1. P.T.V.M. de Jong Age-related macular degeneration N. Engl. J. Med. 355 2006 1474 1485
2. R.D. Jager, W.F. Mieler, and J.W. Miller Age-related macular degeneration N. Engl. J. Med. 358 2008 2606 2617
3. N. Cheung, P. Mitchell, and T.Y. Wong Diabetic retinopathy Lancet 376 2010 124 136
4. T.R. Thrimawithana, S. Young, C.R. Bunt, C. Green, and R.G. Alany Drug delivery to the posterior segment of the eye Drug Discov. Today 16 2011 270 277
5. S. Duvvuri, S. Majumdar, and A.K. Mitra Drug delivery to the retina: challenges and opportunities Expert. Opin. Biol. Ther. 3 2003 45 56
6. J.C. Folk, and E.M. Stone Ranibizumab therapy for neovascular age-related macular degeneration N. Engl. J. Med. 363 2010 1648 1655
7. T.C.R. Group Ranibizumab and bevacizumab for neovascular age-related macular degeneration N. Engl. J. Med. 364 2011 1897 1908
8. P.J. Rosenfeld, D.M. Brown, J.S. Heier, D.S. Boyer, P.K. Kaiser, C.Y. Chung, and R.Y. Kim Ranibizumab for neovascular age-related macular degeneration N. Engl. J. Med. 355 2006 1419 1431
9. A.J. Witkin, and G.C. Brown Update on nonsurgical therapy for diabetic macular edema Curr. Opin. Ophthalmol. 22 2011 185 189
10. W.-C. Chan, S.H. Tsai, A.-C. Wu, L.-J. Chen, and C.-C. Lai Current treatments of diabetic macular edema Int. J. Gerontol. 5 2011 183 188
11. M. Waisbourd, M. Goldstein, and A. Loewenstein Treatment of diabetic retinopathy with anti-VEGF drugs Acta Ophthalmol. 89 2011 203 207
12. M.W. Stewart, P.J. Rosenfeld, F.M. Penha, F.H. Wang, Z. Yehoshua, E. Bueno-Lopez, and P.F. Lopez Pharmacokinetic rationale for dosing every 2 weeks versus 4 weeks with intravitreal ranibizumab, bevacizumab, and aflibercept (vascular endothelial growth factor Trap-eye) Retin.-J. Retin. Vitr. Dis. 32 2012 434 457
13. N. Shelke, R. Kadam, P. Tyagi, V. Rao, and U. Kompella Intravitreal poly(l-lactide) microparticles sustain retinal and choroidal delivery of TG-0054, a hydrophilic drug intended for neovascular diseases Drug Deliv. Transl. Res. 1 2011 76 90
14. R. Herrero-Vanrell Microparticles as drug delivery systems for the back of the eye U.B. Kompella, H.F. Edelhauser, Drug Product Development for the Back of the Eye 2011 Springer New York 231 259
15. A. Bochot, and E. Fattal Liposomes for intravitreal drug delivery: a state of the art J. Control. Release 161 2012 628 634
16. S. Roy, K. Zhang, T. Roth, S. Vinogradov, R.S. Kao, and A. Kabanov Reduction of fibronectin expression by intravitreal administration of antisense oligonucleotides Nat. Biotechnol. 17 1999 476 479
17. R.J. Marano, I. Toth, N. Wimmer, M. Brankov, and P.E. Rakoczy Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity Gene Ther. 12 2005 1544 1550
18. N.N. Sanders, L. Peeters, I. Lentacker, J. Demeester, and S.C. De Smedt Wanted and unwanted properties of surface PEGylated nucleic acid nanoparticles in ocular gene transfer J. Control. Release 122 2007 226 235
19. L. Peeters, N.N. Sanders, K. Braeckmans, K. Boussery, J.V. de Voorde, S.C. De Smedt, and J. Demeester Vitreous: a barrier to nonviral ocular gene therapy Invest. Ophthalmol. Vis. Sci. 46 2005 3553 3561
20. L. Pitkanen, M. Ruponen, J. Nieminen, and A. Urtti Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers Pharm. Res. 20 2003 576 583
21. L.M. Ensign, C. Schneider, J.S. Suk, R. Cone, and J. Hanes Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery Adv. Mater. 24 2012 3887 3894
22. S.K. Lai, Y.-Y. Wang, D. Wirtz, and J. Hanes Micro- and macrorheology of mucus Adv. Drug Deliv. Rev. 61 2009 86 100
23. S.K. Lai, Y.Y. Wang, K. Hida, R. Cone, and J. Hanes Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses Proc. Natl. Acad. Sci. U. S. A. 107 2010 598 603
24. J.S. Suk, S.K. Lai, Y.Y. Wang, L.M. Ensign, P.L. Zeitlin, M.P. Boyle, and J. Hanes The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles Biomaterials 30 2009 2591 2597
25. J.S. Suk, S.K. Lai, N.J. Boylan, M.R. Dawson, M.P. Boyle, and J. Hanes Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine Nanomedicine (London) 6 2011 365 375
26. S.K. Lai, J.S. Suk, A. Pace, Y.-Y. Wang, M. Yang, O. Mert, J. Chen, J. Kim, and J. Hanes Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus Biomaterials 32 2011 6285 6290
27. E.A. Nance, G.F. Woodworth, K.A. Sailor, T.-Y. Shih, Q. Xu, G. Swaminathan, D. Xiang, C. Eberhart, and J. Hanes A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue Sci. Transl. Med. 4 2012 (149ra119)
28. A.J. Kim, N.J. Boylan, J.S. Suk, S.K. Lai, and J. Hanes Non-degradative intracellular trafficking of highly compacted polymeric DNA nanoparticles J. Control. Release 158 2012 102 107
29. N.J. Boylan, A.J. Kim, J.S. Suk, P. Adstamongkonkul, B.W. Simons, S.K. Lai, M.J. Cooper, and J. Hanes Enhancement of airway gene transfer by DNA nanoparticles using a pH-responsive block copolymer of polyethylene glycol and poly-l-lysine Biomaterials 33 2012 2361 2371
30. H.S. Yoo, J.E. Oh, K.H. Lee, and T.G. Park Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release Pharm. Res. 16 1999 1114 1118
31. S.K. Lai, D.E. O'Hanlon, S. Harrold, S.T. Man, Y.Y. Wang, R. Cone, and J. Hanes Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus Proc. Natl. Acad. Sci. U. S. A. 104 2007 1482 1487
32. J. Suh, M. Dawson, and J. Hanes Real-time multiple-particle tracking: applications to drug and gene delivery Adv. Drug Deliv. Rev. 57 2005 63 78
33. B. Amsden An obstruction-scaling model for diffusion in homogeneous hydrogels Macromolecules 32 1999 874 879
34. B. Amsden Solute diffusion within hydrogels. Mechanisms and models Macromolecules 31 1998 8382 8395
35. J.H. Shin, M.L. Gardel, L. Mahadevan, P. Matsudaira, and D.A. Weitz Relating microstructure to rheology of a bundled and cross-linked F-actin network in vitro Proc. Natl. Acad. Sci. U. S. A. 101 2004 9636 9641
36. S.K. Lai, Y.Y. Wang, R. Cone, D. Wirtz, and J. Hanes Altering mucus rheology to "solidify"' human mucus at the nanoscale PLoS One 4 2009 e4294
37. J. Apgar, Y. Tseng, E. Fedorov, M.B. Herwig, S.C. Almo, and D. Wirtz Multiple-particle tracking measurements of heterogeneities in solutions of actin filaments and actin bundles Biophys. J. 79 2000 1095 1106
38. C.S. Nickerson, H.L. Karageozian, J. Park, and J.A. Kornfield Internal tension: a novel hypothesis concerning the mechanical properties of the vitreous humor Macromol. Symp. 227 2005 183 189
39. H. Gupta, M. Aqil, R.K. Khar, A. Ali, A. Bhatnagar, and G. Mittal Biodegradable PLGA nanoparticle for sustained ocular drug delivery J. Pharm. Pharmacol. 62 2010 1253 1254
40. J.F. Xu, Y.S. Wang, Y. Li, X.M. Yang, P. Zhang, H.Y. Hou, Y.Y. Shi, and C.X. Song Inhibitory efficacy of intravitreal dexamethasone acetate-loaded PLGA nanoparticles on choroidal neovascularization in a laser-induced rat model J. Ocul. Pharmacol. Ther. 23 2007 527 539
41. N.J. Boylan, J.S. Suk, S.K. Lai, R. Jelinek, M.P. Boyle, M.J. Cooper, and J. Hanes Highly compacted DNA nanoparticles with low MW PEG coatings: in vitro, ex vivo and in vivo evaluation J. Control. Release 157 2012 72 79
42. P. Bishop The biochemical structure of mammalian vitreous Eye 10 1996 664 670
43. H. Koo, H. Moon, H. Han, J.H. Na, M.S. Huh, J.H. Park, S.J. Woo, K.H. Park, I. Chan Kwon, K. Kim, and H. Kim The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection Biomaterials 33 2012 3485 3493
44. K.J. Bos, D.F. Holmes, R.S. Meadows, K.E. Kadler, D. McLeod, and P.N. Bishop Collagen fibril organisation in mammalian vitreous by freeze etch/rotary shadowing electron microscopy Micron 32 2001 301 306
45. R.G. Brewton, and R. Mayne Mammalian vitreous humor contains networks of hyaluronan molecules: electron microscopic analysis using the hyaluronan-binding region (G1) of aggrecan and link protein Exp. Cell Res. 198 1992 237 249
46. R. Farjo, J. Skaggs, A.B. Quiambao, M.J. Cooper, and M.I. Naash Efficient non-viral ocular gene transfer with compacted DNA nanoparticles PLoS One 1 2006 e38
47. X. Cai, Z. Nash, S.M. Conley, S.J. Fliesler, M.J. Cooper, and M.I. Naash A partial structural and functional rescue of a retinitis pigmentosa model with compacted DNA nanoparticles PLoS One 4 2009 e5290
48. X. Cai, S.M. Conley, Z. Nash, S.J. Fliesler, M.J. Cooper, and M.I. Naash Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa FASEB J. 24 2010 1178 1191
49. S.M. Conley, and M.I. Naash Nanoparticles for retinal gene therapy Prog. Retin. Eye Res. 29 2010 376 397
50. H. Kim, S.B. Robinson, and K.G. Csaky Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina Pharm. Res. 26 2009 329 337
51. D.A. Swann, I.J. Constable, and E. Harper Vitreous structure: III. Composition of bovine vitreous collagen Invest. Ophthalmol. 11 1972 735 738
52. J. Sebag, and K. Yee Vitreous: from biochemistry to clinical relevance W. Tasman, Duane's Foundations of Clinical Ophthalmology 1992 Lippincott Williams & Wilkins Philadelphia